Inactive Instrument

Highlights MURY CANYPAR

Equities

Conduit Pharmaceuticals Limited completed the acquisition of Murphy Canyon Acquisition Corp. from Murphy Canyon Acquisition Sponsor, LLC and others in a reverse merger agreement.	23-09-21	CI
Murphy Canyon Acquisition Corp., Conduit Merger Sub, Inc and Conduit Pharmaceuticals Limited Approve Board Elections	23-09-21	CI
Murphy Canyon Acquisition Shareholders OK Pending Merger with Conduit Pharmaceuticals	23-09-21	MT
Murphy Canyon Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Murphy Canyon Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Conduit Pharmaceuticals Limited entered into a definitive Business Combination Agreement to acquire Murphy Canyon Acquisition Corp. from Murphy Canyon Acquisition Sponsor, LLC and others for approximately $660 million in a reverse merger agreement.	22-11-07	CI
Murphy Canyon Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-07	CI
Murphy Canyon Acquisition Corp. has completed an IPO in the amount of $115 million.	22-02-02	CI
Murphy Canyon Acquisition Corp. has filed an IPO in the amount of $150 million.	22-01-06	CI

No results for this search